Related Experiment Video

Updated: Jul 10, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Understanding the financial impact of MS-DRGs

K C Mitchell1

  • 13M Consulting Services, 3M Health Information Systems, Inc., Atlanta, USA. kcmitchell@mmm.com

Healthcare Financial Management : Journal of the Healthcare Financial Management Association
|November 21, 2007
PubMed

Insights

Hospitals should analyze product line data to identify trends and determine the impact of changes to Medicare's inpatient prospective payment system. Proactive action plans are essential for managing resulting revenue shifts.

Area of Science:

  • Healthcare Administration
  • Health Economics
  • Hospital Management

Background:

  • Medicare's inpatient prospective payment system (IPPS) significantly impacts hospital revenue.
  • Understanding and adapting to IPPS changes is crucial for financial stability.

Purpose of the Study:

  • To outline actionable steps for hospitals preparing for IPPS modifications.
  • To guide healthcare providers in revenue management amidst payment system evolution.

Main Methods:

  • Data analysis within hospital product lines.
  • Identification of trends by physician and Medicare severity diagnosis-related groups (MS-DRGs).
  • Assessment of product line vulnerability to payment system changes.

Main Results:

  • Key product lines susceptible to revenue changes can be identified through data analysis.
  • Specific physician groups or MS-DRGs may experience disproportionate impacts.
  • Proactive planning enables effective management of financial adjustments.

Conclusions:

  • Hospitals must conduct thorough data analysis to anticipate IPPS-related financial shifts.
  • Strategic planning based on identified trends is vital for mitigating revenue risks.
  • Adapting to Medicare payment system changes requires a data-driven approach.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...